FdaApplication
NDA 022510
Identifiers
- fda_app_no: NDA022510
Properties
| Property | Value |
|---|---|
| applicant_name | SENTYNL THERAPEUTICS INC |
| application_type | NDA |
| approval_date | 2011-01-07 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ABSTRAL | FENTANYL CITRATE | EQ 0.8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;SUBLINGUAL |
| ABSTRAL | FENTANYL CITRATE | EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;SUBLINGUAL |
| ABSTRAL | FENTANYL CITRATE | EQ 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;SUBLINGUAL |
| ABSTRAL | FENTANYL CITRATE | EQ 0.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;SUBLINGUAL |
| ABSTRAL | FENTANYL CITRATE | EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;SUBLINGUAL |
| ABSTRAL | FENTANYL CITRATE | EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;SUBLINGUAL |
6 products